However, acquired deficiency of SHP-1 is not likely to be a direct cause of MS, rather it confers susceptibility to auto-inflammatory demyelination if other conditions are met, as has been demonstrated in mice (Croker et al., 2008). Here, NR0B2 is linked to myeloid sarcoma.